Pearce Michael Cooper 4
4 · PERNIX THERAPEUTICS HOLDINGS, INC. · Filed Nov 29, 2012
Insider Transaction Report
Form 4
Pearce Michael Cooper
Director
Transactions
- Exercise/Conversion
Common Stock
2012-11-28$4.20/sh+8,843$37,141→ 45,510 total - Sale
Common Stock
2012-11-28$7.00/sh−8,843$61,901→ 36,667 total - Exercise/Conversion
Common Stock
2012-11-27$4.20/sh+1,100$4,620→ 37,767 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-11-28−8,843→ 0 totalExercise: $4.20Exp: 2013-03-09→ Common Stock (8,843 underlying) - Sale
Common Stock
2012-11-27$7.00/sh−1,100$7,700→ 36,667 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2012-11-27−1,100→ 8,483 totalExercise: $4.20Exp: 2013-03-09→ Common Stock (1,100 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/16/2012.
- [F2]The option which represents a right to purchase a total of 137,500 shares of which 127,917 were purchased prior to 11/27/2012 became fully exercisable on 3/9/2010.